In a meta-analysis of publicly available data sets, Holsten and colleagues detected SMARCA4 PVs as the cause of a rhabdoid tumor in 8/60 PV carriers, indicating incomplete penetrance [16]. This evidence concerns the gene SMARCA4 and rhabdoid tumor.